EP300 and endothelial dysfunction: Our findings identified EP300 as a central epigenetic regulator of endothelial dysfunction in PAH through H3K27ac-dependent activation of NRP1. The EP300-NRP1 axis integrates inflammatory, angiogenic, and metabolic signaling, contributing to endothelial dysfunction and disease onset.